VIVS — VivoSim Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for VivoSim Labs, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28.7	16	2.9	11.3	5.02
Net Total Accounts Receivable
Net Total Receivables	—	0.152	0.033	0.03	0.032
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29.5	17	3.94	12.1	6.63
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.81	2.61	1.97	1.29	0.613
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	33.3	20.3	6.35	14.7	7.39
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.38	3.67	1.86	3.74	2.79
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.09	4.98	2.75	4.16	8.48
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	30.2	15.3	3.6	10.5	-1.1
Total Liabilities & Shareholders' Equity	33.3	20.3	6.35	14.7	7.39
Total Common Shares Outstanding